There are few reports regarding the measurement of cytokines and surface an
alysis of eosinophils in Churg-Strauss syndrome (CSS). To examine the patho
physiology of CSS, concentrations of cytokines in serum and bronchoalveolar
lavage fluid (BALF), and surface antigens on peripheral blood eosinophils
were analyzed in five patients with CSS. Concentrations of cytokines (inter
leukin-1 beta (IL-1 beta), tumor necrosis factor-alpha (TNF-alpha), interle
ukin-3 (IL-3) interleukin-5 (IL-5) and granulocyte/macrophage colony stimul
ating factor (GM-CSF) were measured using ELISA. Surface antigens on eosino
phils in peripheral blood were analyzed using flow cytometry. A concentrati
on of interleukin-5 (IL-5) and TNF-alpha in serum was detected in five case
s; however IL-1 beta, GM-CSF, and IL-3 were detected in 3 of 5, 2 of 5, and
1 of 5 patients, respectively. In BALF, TNF-alpha and IL-5 were detected i
n 2 of 3 and 1 of 3 patients, respectively; however, neither IL-1 beta, GM-
CSF, nor IL-3 was detected in any. Newly expressed surface antigens such as
CD25, CD4, and CD69 were observed on peripheral blood eosinophils in five
cases. CD54 and HLA-DR were expressed in 4 of 5 and 3 of 5 patients, respec
tively. Eosinophils in peripheral blood are activated to various degrees, p
ossibly depending on cytokine stimulation. This eosinophil activation may b
e related to the clinical stage of CSS.